1 study found for:    23200175 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Comparison of AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive Non Small Cell Lung Cancer (NSCLC) Patients
Condition: Non Small Cell Lung Cancer
Interventions: Drug: AZD6244;   Drug: docetaxel;   Drug: Placebo

Indicates status has not been verified in more than two years